153 related articles for article (PubMed ID: 36995898)
21. Esthesioneuroblastoma: The Princess Margaret Hospital experience.
Bachar G; Goldstein DP; Shah M; Tandon A; Ringash J; Pond G; Gullane PJ; Perez-Ordonez B; Gilbert RW; Brown DH; Gentili F; O'Sullivan B; Irish JC
Head Neck; 2008 Dec; 30(12):1607-14. PubMed ID: 18798301
[TBL] [Abstract][Full Text] [Related]
22. Esthesioneuroblastoma: the impact of treatment modality.
Chao KS; Kaplan C; Simpson JR; Haughey B; Spector GJ; Sessions DG; Arquette M
Head Neck; 2001 Sep; 23(9):749-57. PubMed ID: 11505485
[TBL] [Abstract][Full Text] [Related]
23. Comparing Kadish and Modified Dulguerov Staging Systems for Olfactory Neuroblastoma: An Individual Participant Data Meta-analysis.
Arnold MA; Farnoosh S; Gore MR
Otolaryngol Head Neck Surg; 2020 Sep; 163(3):418-427. PubMed ID: 32286935
[TBL] [Abstract][Full Text] [Related]
24. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.
Lechner M; Takahashi Y; Turri-Zanoni M; Liu J; Counsell N; Hermsen M; Kaur RP; Zhao T; Ramanathan M; Schartinger VH; Emanuel O; Helman S; Varghese J; Dudas J; Riechelmann H; Sprung S; Haybaeck J; Howard D; Engel NW; Stewart S; Brooks L; Pickles JC; Jacques TS; Fenton TR; Williams L; Vaz FM; O'Flynn P; Stimpson P; Wang S; Hannan SA; Unadkat S; Hughes J; Dwivedi R; Forde CT; Randhawa P; Gane S; Joseph J; Andrews PJ; Royle G; Franchi A; Maragliano R; Battocchio S; Bewicke-Copley H; Pipinikas C; Webster A; Thirlwell C; Ho D; Teschendorff A; Zhu T; Steele CD; Pillay N; Vanhaesebroeck B; Mohyeldin A; Fernandez-Miranda J; Park KW; Le QT; West RB; Saade R; Manes RP; Omay SB; Vining EM; Judson BL; Yarbrough WG; Sansovini M; Silvia N; Grassi I; Bongiovanni A; Capper D; Schüller U; Thavaraj S; Sandison A; Surda P; Hopkins C; Ferrari M; Mattavelli D; Rampinelli V; Facchetti F; Nicolai P; Bossi P; Henriquez OA; Magliocca K; Solares CA; Wise SK; Llorente JL; Patel ZM; Nayak JV; Hwang PH; Lacy PD; Woods R; O'Neill JP; Jay A; Carnell D; Forster MD; Ishii M; London NR; Bell DM; Gallia GL; Castelnuovo P; Severi S; Lund VJ; Hanna EY
Eur J Cancer; 2022 Feb; 162():221-236. PubMed ID: 34980502
[TBL] [Abstract][Full Text] [Related]
26. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
[TBL] [Abstract][Full Text] [Related]
27. Remote orbital recurrence of olfactory neuroblastoma (esthesioneuroblastoma).
Breazzano MP; Lewis JS; Chambless LB; Rohde SL; Sobel RK
Orbit; 2017 Aug; 36(4):247-250. PubMed ID: 28362545
[TBL] [Abstract][Full Text] [Related]
28. Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade.
Choby G; Geltzeiler M; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; McMillan R; Nayak J; O'Byrne J; Patel C; Patel Z; Peris Celda M; Pinheiro-Neto C; Sanusi O; Snyderman C; Thorp BD; Van Gompel JJ; Young SC; Zenonos G; Zwagerman NT; Wang EW
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):837-844. PubMed ID: 37535372
[TBL] [Abstract][Full Text] [Related]
29. Esthesioneuroblastoma: a meta-analysis and review.
Dulguerov P; Allal AS; Calcaterra TC
Lancet Oncol; 2001 Nov; 2(11):683-90. PubMed ID: 11902539
[TBL] [Abstract][Full Text] [Related]
30. Systematic Review and Meta-Analysis on the Incidence of Level-Specific Cervical Nodal Metastasis in Primary Parotid Malignancies.
Ho JPK; Mair M; Noor A; Fuzi J; Giles M; Ludbrook I; Hoffman G; Winters R; Cope D; Eisenberg R
Otolaryngol Head Neck Surg; 2023 Jun; 168(6):1279-1288. PubMed ID: 36939620
[TBL] [Abstract][Full Text] [Related]
31. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
Xiong L; Zeng XL; Guo CK; Liu AW; Huang L
BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835
[TBL] [Abstract][Full Text] [Related]
32. Patient characteristics of olfactory neuroblastoma: experience from a tertiary cancer centre 2000-2016 covering Eastern Denmark.
Gram SB; Grønhøj C; Mann H; Jakobsen KK; Kiss K; Bilde A; von Buchwald C
APMIS; 2018 Aug; 126(8):663-666. PubMed ID: 30168622
[TBL] [Abstract][Full Text] [Related]
33. [Late neck metastasis in esthesioneuroblastoma: a case report].
Damar M; Başerer N; Ozkara S; Yılmazer R
Kulak Burun Bogaz Ihtis Derg; 2012; 22(4):228-31. PubMed ID: 22770259
[TBL] [Abstract][Full Text] [Related]
34. [The effect of regional neck dissection on positive cervical lymph node of cN0 laryngeal carcinoma].
Li XY; Li JR; Guo HG
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Dec; 31(23):1793-1796. PubMed ID: 29798388
[No Abstract] [Full Text] [Related]
35. The impact of multidisciplinary approaches on the outcomes of olfactory neuroblastoma treated with postoperative radiotherapy.
Tsutsumi Y; Omura K; Kijima Y; Kobayashi M; Fukasawa N; Takeda T; Ebihara T; Aoki S; Otori N; Kojima H; Aoki M
Cancer Med; 2024 Mar; 13(5):e6943. PubMed ID: 38497548
[TBL] [Abstract][Full Text] [Related]
36. A Case of Olfactory Neuroblastoma Developing Bilateral Retropharyngeal Lymph Node Metastasis 14-years After Skull Base Surgery.
Mizumoto M; Furukawa T; Yui M; Iritani K; Tatehara S; Inokuchi G; Teshima M; Shinomiya H; Kimura H; Kiyota N; Sasaki R; Nibu KI
Kobe J Med Sci; 2024 Jun; 70(2):E56-E60. PubMed ID: 38936878
[TBL] [Abstract][Full Text] [Related]
37. Cytopathologic features of olfactory neuroblastoma.
Mahooti S; Wakely PE
Cancer; 2006 Apr; 108(2):86-92. PubMed ID: 16456848
[TBL] [Abstract][Full Text] [Related]
38. Olfactory neuroblastoma: 14-year experience at an Australian tertiary centre and the role for longer-term surveillance.
Schmidt C; Potter N; Porceddu S; Panizza B
J Laryngol Otol; 2017 Jul; 131(S2):S29-S34. PubMed ID: 27917732
[TBL] [Abstract][Full Text] [Related]
39. Treatment and outcome in 12 cases of olfactory neuroblastoma at Mexico´s National Cancer Institute: A retrospective clinical analysis and literature review.
Navarro-Fernández JO; Serrato-Avila JL; Hernández-Varela M; Tejada-Pineda MF; Hernández-Reséndiz RE; Monroy-Sosa A; Cacho-Díaz B; Herrera-Gómez Á; Reyes-Soto G
Cir Cir; 2020; 88(4):453-460. PubMed ID: 32567594
[TBL] [Abstract][Full Text] [Related]
40. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
